17:26 , Sep 14, 2018 |  BC Week In Review  |  Company News

Boston Scientific to acquire Augmenix for $500M

Boston Scientific Corp. (NYSE:BSX) will acquire Augmenix Inc. (Waltham, Mass.) for $500 million in cash up front and up to $100 million in sales milestones. Boston Scientific will gain Augmenix's SpaceOAR hydrogel, which is used...
07:00 , Jul 28, 2014 |  BC Week In Review  |  Financial News

Augmenix completes venture financing

Augmenix Inc. , Waltham, Mass.   Business: Supply/Service   Date completed: 2014-07-23   Type: Venture financing   Raised: $10.8 million   Investors: CHV II; Excelestar Ventures; Catalyst Health Ventures; Sparta Group; individual investors  ...
07:00 , Oct 26, 2009 |  BC Week In Review  |  Financial News

Augmenix completes venture financing

Augmenix Inc. , Waltham, Mass.   Business: Supply/Service   Date completed: 10/16/09   Type: Venture financing   Raised: $6.1 million   Investors: Ascension Health Ventures; Versant Ventures; Pinnacle Ventures; Catalyst Health Ventures; private investors  ...